51. Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach
- Author
-
Jacques Schrenzel, Patrice Francois, Richard A. Proctor, Sébastien Herzig, Alexander Scherl, Michael R. Yeaman, Ali R. Vaezzadeh, Myriam Girard, George Sakoulas, Adrien Nicolas Fischer, Arnold S. Bayer, Soo-Jin Yang, and Ludwig Stenz
- Subjects
Microbiology (medical) ,Staphylococcus aureus ,Proteome ,Quantitative proteomics ,Virulence ,Biology ,Staphylococcal infections ,medicine.disease_cause ,Proteomics ,Microbiology ,Anti-Bacterial Agents/pharmacology ,03 medical and health sciences ,Antibiotic resistance ,Daptomycin ,Staphylococcus aureus/drug effects/isolation & purification ,Recurrence ,ddc:570 ,Drug Resistance, Bacterial ,medicine ,polycyclic compounds ,Proteome/analysis ,Humans ,Pharmacology (medical) ,ddc:576 ,Original Research ,030304 developmental biology ,Pharmacology ,ddc:616 ,0303 health sciences ,030306 microbiology ,Reverse Transcriptase Polymerase Chain Reaction ,Gene Expression Profiling ,Daptomycin/pharmacology ,Nucleic Acid Hybridization ,Endocarditis, Bacterial ,Staphylococcal Infections ,medicine.disease ,bacterial infections and mycoses ,Microarray Analysis ,Anti-Bacterial Agents ,Staphylococcal Infections/microbiology ,Infectious Diseases ,lipids (amino acids, peptides, and proteins) ,Endocarditis, Bacterial/microbiology ,medicine.drug - Abstract
Objectives The development of daptomycin resistance in Staphylococcus aureus is associated with clinical treatment failures. The mechanism(s) of such resistance have not been clearly defined. Methods We studied an isogenic daptomycin-susceptible (DAPS) and daptomycin-resistant (DAPR) S. aureus strain pair (616; 701) from a patient with relapsing endocarditis during daptomycin treatment, using comparative transcriptomic and proteomic techniques. Results Minor differences in the genome content were found between strains by DNA hybridization. Transcriptomic analyses identified a number of genes differentially expressed in important functional categories: cell division; metabolism of bacterial envelopes; and global regulation. Of note, the DAPR isolate exhibited reduced expression of the major cell wall autolysis gene coincident with the up-regulation of genes involved in cell wall teichoic acid production. Using quantitative (q)RT-PCR on the gene cadre putatively involved in cationic peptide resistance, we formulated a putative regulatory network compatible with microarray data sets, mainly implicating bacterial envelopes. Of interest, qRT-PCR of this same gene cadre from two distinct isogenic DAPS/DAPR clinical strain pairs revealed evidence of other strain-dependent networks operative in the DAPR phenotype. Comparative proteomics of 616 versus 701 revealed a differential abundance of proteins in various functional categories, including cell wall-associated targets and biofilm formation proteins. Phenotypically, strains 616 and 701 showed major differences in their ability to develop bacterial biofilms in the presence of the antibacterial lipid, oleic acid. Conclusions Compatible with previous in vitro observations, in vivo-acquired DAPR in S. aureus is a complex, multistep phenomenon involving: (i) strain-dependent phenotypes; (ii) transcriptome adaptation; and (iii) modification of the lipid and protein contents of cellular envelopes
- Published
- 2011